Enovis Corporation – NYSE:ENOV
Enovis stock price today
$30.674
-13.61
-30.74%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Enovis stock price monthly change
-3.78%
month
Enovis stock price quarterly change
-3.78%
quarter
Enovis stock price yearly change
-21.78%
year
Enovis key metrics
Market Cap | 2.42B |
Enterprise value | 3.25B |
P/E | -75.1 |
EV/Sales | 1.47 |
EV/EBITDA | 11.09 |
Price/Sales | 1.32 |
Price/Book | 0.85 |
PEG ratio | 0.63 |
EPS | -1.49 |
Revenue | 1.81B |
EBITDA | 129.57M |
Income | -81.90M |
Revenue Q/Q | 27.11% |
Revenue Y/Y | 14.02% |
Profit margin | -0.6% |
Oper. margin | -0.07% |
Gross margin | 49.47% |
EBIT margin | -0.07% |
EBITDA margin | 7.13% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEnovis stock price history
Enovis stock forecast
Enovis financial statements
Average Price Target
$65
Potential upside: 111.90%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 428.50M | -9.99M | -2.33% |
|---|---|---|---|
| Sep 2023 | 417.52M | -2.88M | -0.69% |
| Dec 2023 | 455.02M | 2.96M | 0.65% |
| Mar 2024 | 516.26M | -71.99M | -13.95% |
| Jun 2023 | 4443553000 | 992.79M | 22.34% |
|---|---|---|---|
| Sep 2023 | 4400917000 | 959.18M | 21.8% |
| Dec 2023 | 4509334000 | 1.08B | 24.14% |
| Mar 2024 | 5478681000 | 2.16B | 39.57% |
| Jun 2023 | 28.10M | -131.60M | 114.21M |
|---|---|---|---|
| Sep 2023 | 31.01M | -17.10M | -13.70M |
| Dec 2023 | 68.41M | -59.37M | 2.78M |
| Mar 2024 | -36.15M | -797.84M | 864.54M |
Enovis alternative data
| Aug 2023 | 6,800 |
|---|---|
| Sep 2023 | 6,800 |
| Oct 2023 | 6,800 |
| Nov 2023 | 6,800 |
| Dec 2023 | 6,800 |
| Jan 2024 | 6,800 |
| Feb 2024 | 6,800 |
| Mar 2024 | 6,550 |
| Apr 2024 | 6,550 |
| May 2024 | 6,550 |
| Jun 2024 | 6,550 |
| Jul 2024 | 6,550 |
Enovis other data
83.77%
-16.23%
of ENOV is owned by hedge funds
213
-24
45.67M
-2.46M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Nov 2022 | 0 | 67421 |
| Dec 2022 | 0 | 1367 |
| Feb 2023 | 0 | 52791 |
| Mar 2023 | 0 | 15973 |
| Apr 2023 | 0 | 695 |
| May 2023 | 0 | 1396 |
| Jun 2023 | 0 | 645 |
| Jul 2023 | 0 | 67 |
| Aug 2023 | 0 | 174 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | KLECKNER JOHN officer: Principal Accounting O.. | Common stock, par value $0.001 | 174 | $59.18 | $10,297 | ||
Sale | KLECKNER JOHN officer: Principal Accounting O.. | Common stock, par value $0.001 | 67 | $65.32 | $4,376 | ||
Sale | BERRY PHILLIP BENJAMIN (BEN) officer: SVP, Chief Financial O.. | Common stock, par value $0.001 | 645 | $54.17 | $34,940 | ||
Option | VINNAKOTA RAJIV director | Director stock option (right to buy) | 1,396 | $42.43 | $59,232 | ||
Option | VINNAKOTA RAJIV director | Common stock, par value $0.001 | 1,396 | $42.43 | $59,232 | ||
Sale | VINNAKOTA RAJIV director | Common stock, par value $0.001 | 1,396 | $57.18 | $79,823 | ||
Sale | SHIRLEY BRADY director, officer.. | Common stock, par value $0.001 | 695 | $53.54 | $37,210 | ||
Sale | SHIRLEY BRADY director, officer.. | Common stock, par value $0.001 | 695 | $53.54 | $37,210 | ||
Sale | BERRY PHILLIP BENJAMIN (BEN) officer: SVP, Chief Financial O.. | Common stock, par value $0.001 | 600 | $51.84 | $31,104 | ||
Option | PERFALL A CLAYTON director | Director stock option (right to buy) | 2,793 | $42.43 | $118,507 |
| Quarter | Transcript |
|---|---|
| Q1 2024 2 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 22 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 7 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 6 Aug 2023 | Q2 2023 Earnings Call Transcript |
Lincoln Electric: Quality Business Has Regained Its Quality Price
ESAB Corporation: Well Done, By The Welding Player
Enovis Corporation: Things Are Looking Good As Guidance Is Raised
ESAB Corporation: Upside Exists Despite Recent Bottom Line Weakness
ESAB Corp.: Looks To Be A Solid Welding Play After The Spin-Off
-
What's the price of Enovis stock today?
One share of Enovis stock can currently be purchased for approximately $30.67.
-
When is Enovis's next earnings date?
Unfortunately, Enovis's (ENOV) next earnings date is currently unknown.
-
Does Enovis pay dividends?
No, Enovis does not pay dividends.
-
How much money does Enovis make?
Enovis has a market capitalization of 2.42B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 9.22% to 1.71B US dollars.
-
What is Enovis's stock symbol?
Enovis Corporation is traded on the NYSE under the ticker symbol "ENOV".
-
What is Enovis's primary industry?
Company operates in the Industrials sector and Industrial - Machinery industry.
-
How do i buy shares of Enovis?
Shares of Enovis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Enovis have?
As Jul 2024, Enovis employs 6,550 workers.
-
When Enovis went public?
Enovis Corporation is publicly traded company for more then 17 years since IPO on 8 May 2008.
-
What is Enovis's official website?
The official website for Enovis is enovis.com.
-
Where are Enovis's headquarters?
Enovis is headquartered at 2711 Centerville Road, Wilmington, DE.
-
How can i contact Enovis?
Enovis's mailing address is 2711 Centerville Road, Wilmington, DE and company can be reached via phone at +30 22529190.
-
What is Enovis stock forecast & price target?
Based on 1 Wall Street analysts` predicted price targets for Enovis in the last 12 months, the avarage price target is $65. The average price target represents a 111.90% change from the last price of $30.67.
Enovis company profile:
Enovis Corporation
enovis.comExchange:
NYSE
Full time employees:
6,550
Industry:
Industrial - Machinery
Sector:
Industrials
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.
2711 Centerville Road
Wilmington, DE 19808
Wilmington, DE 19808
CIK: 0001420800
ISIN: US1940145022
CUSIP: 194014502
